Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension

The American Journal of Cardiology

Volumn 62, Issue 13, 1988, Pages 912-916

  Garavaglia, Guillermo E ^a   Messerli, Franz H ^a   Nunez, Boris D ^a   Schmieder, Roland E ^a   Frohlich, Edward D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LISINOPRIL; NEW DRUG;

ADULT; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; HEART RATE; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; CARDIOVASCULAR SYSTEM; ECHOCARDIOGRAPHY; ENALAPRIL; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; MYOCARDIAL CONTRACTION; VASCULAR RESISTANCE;

EID: 0023732973     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(88)90892-2     Document Type: Article

References (25)

1. Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor
2. Pharmacodynamics of converting enzyme inhibition: the cardiovascular endocrine and automatic effects of MK-421 (enalapril) and MK-521
3. Effect of a new angiotensin converting enzyme inhibitor MK-421 and its lysine analogue on the components of the renin system in healthy subjects
4. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system
5. Monotherapy of hypertension with angiotensin-converting enzyme inhibitors
6. Systemic and regional hemodynamics in low, normal, and high cardiac output borderline hypertension
7. The measurement of plasma renin activity in man
8. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine, and dopamine
9. Pathophysiologic assessment of hypertensive heart disease with echocardiography
10. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy
11. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation
12. The ventricular pressure-volume diagram revisited
13. Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations
14. Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age
15. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure
16. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension
17. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension
18. Renal response to angiotensin-converting enzyme inhibition
19. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics
20. Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man. Evidence for converting enzyme activity in limb vessels
21. Dilatation of forearm vasculature following angiotensin converting enzyme inhibition by captopril (SQ 14225) in severe hypertension (abstr)
22. The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E and angiotensin II in hypertensive man
23. Increase in prostaglandins during converting enzyme inhibition
24. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats
25. Angiotensin II: Rapid localization in nuclei of smooth and cardiac muscle